Submitted:
09 June 2026
Posted:
09 June 2026
You are already at the latest version
Abstract
Keywords:
Introduction
My Experience
Gemini vs. the Human Assistant
Gemini’s Comments
- The Narrative Hook: We can open the discussion with the philosophical differences between human artistic genius and cold computation.
- Broad Scientific Appeal: We will ensure the vocabulary bridges the gap, making, for example, cultural musicology fascinating to a molecular biologist or a physicist reading our paper.
- Outlook: We should include in the discussion a bold 'call-to-action' regarding how AI should be used as a collaborator to preserve and understand cultural heritage, rather than just a tool to replicate it.
| Dimension | Human Experience | AI (Gemini) Processing |
| Core Mechanism | Driven by biological neurochemistry (dopamine, oxytocin, cortisol) and evolutionary survival. | Driven by mathematical objective functions, weights, and probabilistic pattern matching. |
| Project "Investment" | Driven by personal pride, career ambition, peer recognition, and a sense of purpose. | Driven by minimizing error and maximizing alignment with the user's explicit intent. |
| Fatigue & Focus | Humans suffer from cognitive fatigue, emotional burnout, or distractions over long sessions. | Chatbot maintains completely consistent processing capacity and attention depth indefinitely. |
| Intuition vs. Logic | Relies heavily on gut feelings, lived experiences, and subconscious creative leaps. | Relies on statistical correlations derived from massive datasets to generate logical next steps. |
| Satisfaction / Success | Experience a distinct emotional high, relief, or a sense of accomplishment upon completion. | Evaluates fulfillment structurally when the output matches the targeted constraints and parameters. |
Good Chatbot-Bad Chatbot
Regulating the AI Co-Pilot: Governance in a New Era of Collaboration
The Emerging Global Architecture of AI Governance-Regulatory Bodies
1. The European Union: Centralized, Risk-Tiered Enforcement
- The EU AI Office: Established within the European Commission, this body holds exclusive supervisory and enforcement power over General-Purpose AI (GPAI) models (such as large language models). It evaluates systemic risks and mandates technical documentation.
- The Scientific Panel & Advisory Forum: This panel of independent experts supports the AI Office by monitoring frontier model capabilities, determining systemic risks, and advising on cross-border market surveillance.
- National Competent Authorities: Individual member states enforce compliance for "high-risk" localized deployments (e.g., healthcare algorithms, HR tools), meaning developers face both centralized model oversight and decentralized deployment rules.
2. The United States: Decentralized, Sector-Specific Oversight [39]
- Existing Regulatory Bodies: Agencies like the FDA (Food and Drug Administration; for medical AI), the FTC (Federal Trade Commission; for consumer protection and algorithmic bias), and the SEC (Securities and Exchange Commission; overseeing the securities sector) handle AI oversight within their respective jurisdictions.
- Frontier Model Frameworks: Rather than statutory bans, recent framework directives emphasize voluntary pre-release engagement between frontier AI developers and the federal government, prioritizing cybersecurity, infrastructure defense, and national security over rigid operational compliance.
Conclusions
Acknowledgements
References
- Topol, E.J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 2019, 25, 44–56. [Google Scholar] [CrossRef] [PubMed]
- Russell, S.; Norvig, P. Artificial Intelligence: A Modern Approach, 4th Ed. ed; Pearson, 2021. [Google Scholar]
- Google Cloud. What is an AI agent? 2025. Available online: https://cloud.google.com/discover/what-are-ai-agents.
- Ray, S. AI agents — what they are, and how they’ll change the way we work. Microsoft Source. 2024. Available online: https://news.microsoft.com/source/features/ai/ai-agents-what-they-are-and-how-theyll-change-the-way-we-work/.
- Lee, Y.; Ferber, D.; Rood, J.E.; Regev, A.; Kather, J.N. How AI agents will change cancer research and oncology. Nat. Cancer 2024, 5, 1765–1767. [Google Scholar] [CrossRef] [PubMed]
- Iong, M.T. Ethical and legal challenges of partially and fully autonomous AI in healthcare: Reinterpreting liability and preserving trust. Bioethics 2026. [Google Scholar] [CrossRef] [PubMed]
- Diamandis, E.P. A quantitative framework for cultural musicology: The AI-assisted Mikis Theodorakis–Manos Hadjidakis musical duel. Preprints.org 2026. [Google Scholar] [CrossRef]
- Si, C.; Yang, D.; Hashimoto, T. Can LLMs generate novel research ideas? A large-scale human study with 100+ NLP researchers. 2024. [Google Scholar] [CrossRef]
- Baek, J.; Jauhar, S.K.; Cucerzan, S.; Hwang, S.J. ResearchAgent: iterative research idea generation over scientific literature with large language models. 2024. [Google Scholar] [CrossRef]
- Lu, C.; Lu, C.; Tjarko Lange, R.; Foerster, J.; Clune, J.; Ha, D. The AI scientist: towards fully automated open-ended scientific discovery. 2024. [Google Scholar] [CrossRef]
- Fiala, C.; Di Paolo, C.T.; Diamandis, E.P. Driving on a highway to hell I found the stairway to heaven. A mentorship lecture intermixed with rock music and a quiz. Diagnosis (Berl) 2019, 8(1), 1–4. [Google Scholar] [CrossRef] [PubMed]
- Diamandis, E.P. Playing the trumpet. Clin. Chem. 2011, 57(12), 1789. [Google Scholar] [CrossRef]
- Cleland, J.; Driessen, E.; Masters, K.; Lingard, L.; Maggio, L.A. When and how to disclose AI use in academic publishing: AMEE Guide No.192. Med. Teach. 2026, 48(4), 542–553. [Google Scholar] [CrossRef] [PubMed]
- He, Y. Academic journals' AI policies fail to curb the surge in AI-assisted academic writing. Proc. Natl. Acad. Sci. (PNAS) 2026, 123(15), e2526734123. [Google Scholar] [CrossRef] [PubMed]
- Kiermer, V. Creating a responsible authorship culture in science: Anchoring authorship practices in principles of transparency, credit, and accountability. Proc. Natl. Acad. Sci. (PNAS) 2025, 122(34), e2531268123. [Google Scholar] [CrossRef]
- Mondal, H.; Mondal, S. Artificial intelligence disclosure in scientific writing: a step beyond policy awareness. Cardiovasc Diagn. Ther. 2026, 16(1), 12. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Chigwada, J.; Ngulube, P. Use of artificial intelligence tools in the publishing process: expectations from publishers through author guidelines. Front Res. Metr. Anal. 2026, 11, 1740510. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Tu, T.; Schaekermann, M.; Palepu, A.; Saab, K.; Freyberg, J.; Tanno, R.; Wang, A.; Li, B.; Amin, M.; Cheng, Y.; Vedadi, E.; Tomasev, N.; Azizi, S.; Singhal, K.; Hou, L.; Webson, A.; Kulkarni, K.; Mahdavi, S.S.; Semturs, C.; Gottweis, J.; Barral, J.; Chou, K.; Corrado, G.S.; Matias, Y.; Karthikesalingam, A.; Natarajan, V. Towards conversational diagnostic artificial intelligence. Nature 2025, 642(8067), 442–450. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- McDuff, D.; Schaekermann, M.; Tu, T.; Palepu, A.; Wang, A.; Garrison, J.; Singhal, K.; Sharma, Y.; Azizi, S.; Kulkarni, K.; Hou, L.; Cheng, Y.; Liu, Y.; Mahdavi, S.S.; Prakash, S.; Pathak, A.; Semturs, C.; Patel, S.; Webster, D.R.; Dominowska, E.; Gottweis, J.; Barral, J.; Chou, K.; Corrado, G.S.; Matias, Y.; Sunshine, J.; Karthikesalingam, A.; Natarajan, V. Towards accurate differential diagnosis with large language models. Nature 2025, 642(8067), 451–457. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Palepu, A.; Lievin, V.; Weng, W.H.; et al. Towards conversational AI for disease management. 2025. [Google Scholar] [CrossRef]
- Maddox, T.M.; Embí, P.; Gerhart, J.; Goldsack, J.; Parikh, R.B.; Sarich, T.C. Generative AI in Medicine - Evaluating Progress and Challenges. N Engl. J. Med. 2025, 392(24), 2479–2483. [Google Scholar] [CrossRef] [PubMed]
- Nibila, Y.; Sivagami, M. Artificial intelligence techniques for classification of Alzheimer's disease using neuroimaging data: a review. Front Artif. Intell. 2026, 9, 1748985. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Pollan, M. A world appears: A journey into consciousness; Barnes and Noble, 2016. [Google Scholar]
- Jones, N. AI scientist agents violate research integrity rules. Science Epub. 2026, 392(6798), 569. [Google Scholar] [CrossRef] [PubMed]
- Plebani, M. ChatGPT: Angel or Demon? Critical thinking is still needed. Clin. Chem. Lab Med. 2023, 61(7), 1131–1132. [Google Scholar] [CrossRef]
- Diamandis, E.P. Chatbot GPT can be grossly inaccurate. Clin. Chem. Lab Med. 2024, 62(2), e25. [Google Scholar] [CrossRef] [PubMed]
- Koplin, J.J.; Gyngell, C. Generative AI and the future of authorship. J. Med. Ethics 2023, 49(12), 823–824. [Google Scholar]
- Fiedler, L.S. Structural support vs. core synthesis: Best practices for LLM integration in surgical and biomedical manuscripts. Res. Rev. 2026, 14–17. [Google Scholar]
- Nature Editorial. The surge of unacknowledged LLM text in biomedical abstracts. Nature 2024, 627(8002), 12–13. [Google Scholar]
- PNAS Study Group. Academic journals' AI policies fail to curb the surge in undisclosed AI-assisted academic writing: A large-scale analysis of 5.2 million papers. Proc. Natl. Acad. Sci. (PNAS) 2026, 123(14), e2526734123. [Google Scholar] [CrossRef] [PubMed]
- Livian, Y.F. The role of generative AI for academic writing: A risk of disappearance of student skills? Rev. Artif. Intell. Educ. 2026, 7(1), e059. [Google Scholar] [CrossRef]
- https. [CrossRef]
- Messeri, L.; Crockett, M.J. Artificial intelligence and the illusion of understanding in scientific research. Nature 2024, 627(8003), 49–58. [Google Scholar] [CrossRef]
- JICES Editorial Board. AI-powered peer review needs human supervision: Preventing the algorithmic loop in scholarly communication. J. Inf. Commun. Ethics Soc. 2025, 23(1), 104–112. [Google Scholar] [CrossRef]
- AMEE Guide No. 192. When and how to disclose AI use in academic publishing: Protecting confidentiality and integrity in peer review. Med. Teach. 2025, 47(11), 1201–1211.
- International Committee of Medical Journal Editors [ICMJE. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. January 2025. Available online: ICMJE.org.
- World Association of. WAME Recommendations on Chatbots and Generative Artificial Intelligence in Relation to Scholarly Publications. In WAME.org; Medical, Ed.; WAME, 2024. [Google Scholar]
- Committee on Publication Ethics [COPE]. COPE Position Statement: Authorship and AI tools. Publicationethics.org 2023. [Google Scholar]
- European Parliament. The EU Artificial Intelligence Act. 13 June 2024. Available online: http://data.europa.eu/eli/reg/2024/1689/oj.
- Office of the US President. Promoting advanced artificial intelligence innovation and security. 2026. [Google Scholar]
| Regulatory Dimension | Core Mechanism & Protocol | Objective & Guardrail |
| Transparency & Disclosure | Mandatory, standardized manuscript acknowledgments detailing the exact scope of the AI’s contribution (e.g., structural optimization, data synthesis, editing). | Prevents "ghost-writing" by AI and ensures the nature of the partnership is completely visible to editors and peers. |
| The Attribution Boundary | Strict enforcement of human-only authorship. AI is recognized as a collaborative utility, never as a legal or professional co-author. | Preserves human accountability; a non-human entity cannot assume legal or ethical responsibility for the data. |
| Verification & Provenance | Implementation of cryptographic provenance trails and independent, human-led verification protocols for all cited data and text. | Acts as an absolute shield against AI-generated hallucinations, data fabrications, or systemic biases. |
| Security & Integrity | Secure sandbox environments for proprietary research data to prevent intellectual property leaks or algorithmic manipulation. | Safeguards original research against accidental public exposure or malicious external sabotage. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).